Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Applying the bacterial meningitis score in children with cerebrospinal fluid pleocytosis: a single center's experience

  • Lee, Jungpyo (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kwon, Hyeeun (Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Joon Soo (Division of Pediatric Neurology, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kim, Heung Dong (Division of Pediatric Neurology, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kang, Hoon-Chul (Division of Pediatric Neurology, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • 투고 : 2014.08.19
  • 심사 : 2014.10.19
  • 발행 : 2015.07.10
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The widespread introduction of bacterial conjugate vaccines has decreased the risk of cerebrospinal fluid (CSF) pleocytosis due to bacterial meningitis (BM) in children. However, most patients with CSF pleocytosis are hospitalized and treated with parenteral antibiotics for several days. The bacterial meningitis score (BMS) is a validated multivariate model derived from a pediatric population in the postconjugate vaccine era and has been evaluated in several studies. In the present study, we examined the usefulness of BMS in South Korean patients. Methods: This study included 1,063 patients with CSF pleocytosis aged between 2 months and 18 years. The BMS was calculated for all patients, and the sensitivity and negative predictive value (NPV) of the test were evaluated. Results: Of 1,063 patients, 1,059 (99.6%) had aseptic meningitis (AM). Only four patients (0.4%) had BM. The majority of patients (98%) had a BMS of ${\leq}1$, indicating a diagnosis of AM. The BMS was 0 in 635 patients (60%) and 1 in 405 patients (38%). All four BM patients had a BMS of ${\geq}4$. Conclusion: To our knowledge, this is the first study to investigate the diagnostic strength of the BMS in South Korea. In our study, the BMS showed 100% sensitivity and 100% NPV. Therefore, we believe that the BMS is a good clinical prediction rule to identify children with CSF pleocytosis who are at a risk of BM.

키워드

참고문헌

  1. Nigrovic LE, Kuppermann N, Malley R. Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era. Pediatrics 2002;110:712-9. https://doi.org/10.1542/peds.110.4.712
  2. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997;337:970-6. https://doi.org/10.1056/NEJM199710023371404
  3. Dubos F, Lamotte B, Bibi-Triki F, Moulin F, Raymond J, Gendrel D, et al. Clinical decision rules to distinguish between bacterial and aseptic meningitis. Arch Dis Child 2006;91:647-50. https://doi.org/10.1136/adc.2005.085704
  4. Nigrovic LE, Kuppermann N, Macias CG, Cannavino CR, Moro-Sutherland DM, Schremmer RD, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA 2007;297:52-60. https://doi.org/10.1001/jama.297.1.52
  5. Nigrovic LE, Malley R, Kuppermann N. Meta-analysis of bacterial meningitis score validation studies. Arch Dis Child 2012;97:799-805. https://doi.org/10.1136/archdischild-2012-301798
  6. Schlech WF 3rd, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA 1985;253:1749-54. https://doi.org/10.1001/jama.1985.03350360075022
  7. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011;364:2016-25. https://doi.org/10.1056/NEJMoa1005384
  8. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990;162:1316-23. https://doi.org/10.1093/infdis/162.6.1316
  9. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106(2 Pt 1):362-6. https://doi.org/10.1542/peds.106.2.362
  10. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6. https://doi.org/10.1001/jama.1993.03500020055031
  11. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17. https://doi.org/10.1128/CMR.13.2.302-317.2000
  12. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378-88. https://doi.org/10.1056/NEJM200105033441807
  13. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. https://doi.org/10.1056/NEJMoa022823
  14. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009;360:244-56. https://doi.org/10.1056/NEJMoa0800836
  15. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113(3 Pt 1):443-9. https://doi.org/10.1542/peds.113.3.443
  16. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010; 9:285-98. https://doi.org/10.1586/erv.10.3
  17. Peltola H, Roine I. Improving the outcomes in children with bacterial meningitis. Curr Opin Infect Dis 2009;22:250-5. https://doi.org/10.1097/QCO.0b013e328329c47a
  18. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84. https://doi.org/10.1086/425368
  19. Aguero G, Davenport MC, Del Valle Mde L, Gallegos P, Kannemann AL, Bokser V, et al. Validation of a clinical prediction rule to distinguish bacterial from aseptic meningitis. Arch Argent Pediatr 2010;108:40-4.
  20. Dubos F, De la Rocque F, Levy C, Bingen E, Aujard Y, Cohen R, et al. Sensitivity of the bacterial meningitis score in 889 children with bacterial meningitis. J Pediatr 2008;152:378-82. https://doi.org/10.1016/j.jpeds.2007.07.012
  21. Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, et al. Distinguishing between bacterial and aseptic meningitis in children: European comparison of two clinical decision rules. Arch Dis Child 2010;95:963-7. https://doi.org/10.1136/adc.2010.186056
  22. Pierart J, Lepage P. Value of the "Bacterial Meningitis Score" (BMS) for the differential diagnosis of bacterial versus viral meningitis. Rev Med Liege 2006;61:581-5.
  23. Tuerlinckx D, El Hayeck J, Van der Linden D, Bodart E, Glupczynski Y. External validation of the bacterial meningitis score in children hospitalized with meningitis. Acta Clin Belg 2012;67:282-5.
  24. Bailey EM, Domenico P, Cunha BA. Bacterial or viral meningitis? Measuring lactate in CSF can help you know quickly. Postgrad Med 1990;88:217-9, 223.
  25. Freedman SB, Marrocco A, Pirie J, Dick PT. Predictors of bacterial meningitis in the era after Haemophilus influenzae. Arch Pediatr Adolesc Med 2001;155:1301-6. https://doi.org/10.1001/archpedi.155.12.1301
  26. Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997;24:1240-2. https://doi.org/10.1086/513633
  27. Hansson LO, Axelsson G, Linne T, Aurelius E, Lindquist L. Serum C-reactive protein in the differential diagnosis of acute meningitis. Scand J Infect Dis 1993;25:625-30. https://doi.org/10.3109/00365549309008552
  28. Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 1999;29:69-74. https://doi.org/10.1086/520184
  29. Lopez-Cortes LF, Marquez-Arbizu R, Jimenez-Jimenez LM, Jimenez-Mejias E, Caballero-Granado FJ, Rey-Romero C, et al. Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med 2000;28:215-9. https://doi.org/10.1097/00003246-200001000-00035
  30. Michelow IC, Nicol M, Tiemessen C, Chezzi C, Pettifor JM. Value of cerebrospinal fluid leukocyte aggregation in distinguishing the causes of meningitis in children. Pediatr Infect Dis J 2000;19:66-72. https://doi.org/10.1097/00006454-200001000-00013
  31. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000;105:316-9. https://doi.org/10.1542/peds.105.2.316
  32. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000;28:1828-32. https://doi.org/10.1097/00003246-200006000-00024
  33. Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999;28:1313-6. https://doi.org/10.1086/514793
  34. Choe YJ, Yang JJ, Park SK, Choi EH, Lee HJ. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. J Korean Med Sci 2013; 28:1283-8. https://doi.org/10.3346/jkms.2013.28.9.1283
  35. Smith AL. Oral antibiotic therapy for serious infections. Annu Rev Med 1988;39:171-84. https://doi.org/10.1146/annurev.me.39.020188.001131

피인용 문헌

  1. Expression of MMP-2 and TIMP-1 in cerebrospinal fluid and the correlation with dynamic changes of serum PCT in neonatal purulent meningitis vol.15, pp.2, 2015, https://doi.org/10.3892/etm.2017.5543
  2. Cerebrospinal fluid culture-positive bacterial meningitis increases the risk for neurologic damage among neonates vol.53, pp.1, 2015, https://doi.org/10.1080/07853890.2021.2004318